×
News Home

Can Adverum Biotechnologies Inc (ADVM) Stock Rise to the Top of Healthcare Sector Wednesday?

Wednesday, October 05, 2022 02:59 PM | InvestorsObserver Analysts
Can Adverum Biotechnologies Inc (ADVM) Stock Rise to the Top of Healthcare Sector Wednesday?

A rating of 64 puts Adverum Biotechnologies Inc (ADVM) near the top of the Healthcare sector according to InvestorsObserver. Adverum Biotechnologies Inc's score of 64 means that it ranks higher than 64% of stocks in the sector. In addition, its overall score of 8 ranks it higher than 8% of all stocks.

Overall Score - 8
ADVM has an Overall Score of 8. Find out what this means to you and get the rest of the rankings on ADVM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Adverum Biotechnologies Inc Stock Today?

Adverum Biotechnologies Inc (ADVM) stock is higher by 1.94% while the S&P 500 is down -0.12% as of 2:41 PM on Wednesday, Oct 5. ADVM is up $0.02 from the previous closing price of $1.03 on volume of 125,873 shares. Over the past year the S&P 500 is lower by -12.87% while ADVM is down -51.39%. ADVM lost -$1.57 per share the over the last 12 months. Click Here to get the full Stock Report for Adverum Biotechnologies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App